Navigation Links
Amgen Positioned to Deliver Attractive Growth Over Next Five Years
Date:11/7/2008

arketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administ
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
5. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
6. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
7. Amgen Announces Webcast of 2008 Third Quarter Financial Results
8. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
9. Call for Applications: The Amgen Award for Science Teaching Excellence
10. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
11. New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 31, 2015 , ... Global Resorcinol Market 2015-2019 is a ... the global resorcinol industry. The report highlights the various growth prospects and the ... analysis of primary and secondary inputs from the existing players of the resorcinol ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud ... partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official ... Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific ...
(Date:7/30/2015)... 30, 2015 AACC welcomed thousands of ... AACC Annual Meeting & Clinical Lab Expo in ... The meeting showcased revolutionary advancements in clinical testing ... healthcare providers to diagnose patients quickly and accurately ... As of Wednesday, July 29, ...
(Date:7/30/2015)... USA (PRWEB) , ... July 30, 2015 , ... ... microsystems, has appointed Francois Vieillard as Sales & Marketing Director. , With ... Francois Vieillard will be responsible for reinforcing Tronics’ business development activities worldwide. He ...
Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2
... Hitech(TM), a focus area of,SAFC(R) and part of ... that it will be participating in a webcast, ... to discuss,the subject of Atomic Layer Deposition (ALD). ... (NAND and NOR) technologies that could be,addressed by ...
... system treats cancer, patients quickly and ... OAK, Mich., Oct. 30 Beaumont Hospital, Royal ... treatments using the new,Elekta Axesse(TM), the ultimate whole-body ... precision and therapeutic efficacy in,stereotactic radiation therapy, which ...
... Diagnostics Grows 9.4%; On Target to ... Achieve Full Year Outlook, ... a leading developer, manufacturer and marketer of,products that simplify, automate and ... results. Total,revenue of $669 million was up 6.0% over third quarter ...
Cached Biology Technology:SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast 2SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast 3Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse 2Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse 3Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse 4Beckman Coulter Announces Third Quarter 2007 Results 2Beckman Coulter Announces Third Quarter 2007 Results 3Beckman Coulter Announces Third Quarter 2007 Results 4Beckman Coulter Announces Third Quarter 2007 Results 5Beckman Coulter Announces Third Quarter 2007 Results 6Beckman Coulter Announces Third Quarter 2007 Results 7Beckman Coulter Announces Third Quarter 2007 Results 8Beckman Coulter Announces Third Quarter 2007 Results 9Beckman Coulter Announces Third Quarter 2007 Results 10Beckman Coulter Announces Third Quarter 2007 Results 11Beckman Coulter Announces Third Quarter 2007 Results 12Beckman Coulter Announces Third Quarter 2007 Results 13Beckman Coulter Announces Third Quarter 2007 Results 14Beckman Coulter Announces Third Quarter 2007 Results 15Beckman Coulter Announces Third Quarter 2007 Results 16Beckman Coulter Announces Third Quarter 2007 Results 17Beckman Coulter Announces Third Quarter 2007 Results 18Beckman Coulter Announces Third Quarter 2007 Results 19Beckman Coulter Announces Third Quarter 2007 Results 20Beckman Coulter Announces Third Quarter 2007 Results 21Beckman Coulter Announces Third Quarter 2007 Results 22Beckman Coulter Announces Third Quarter 2007 Results 23Beckman Coulter Announces Third Quarter 2007 Results 24Beckman Coulter Announces Third Quarter 2007 Results 25
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:7/2/2015)... 2, 2015 Fingerprint Cards has received ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... be used by smartphone manufacturers in Asia ... the communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... A team of researchers from the Wildlife Conservation Society (WCS) ... South American sea bird called an imperial cormorant with a ... diving 150 feet underwater in 40 seconds, feeding on the ... snakelike fish, before returning to the surface 40 seconds later. ...
... Cold feetthose chilly appendages that plague many people in ... the bane of existence for singles and couples alike. In ... the Research Institute at Nationwide Children,s Hospital have identified a ... interaction between a series of molecules and receptors on smooth ...
... improve low cost methods for carbon capture. Scientists from ... synchrotron to investigate the efficiency of calcium oxide (CaO) ... published in the journal of Energy & Environmental ... key mechanisms involved. This new knowledge will inform efforts ...
Cached Biology News:Are cold feet plaguing your relationship? 2Are cold feet plaguing your relationship? 3Low-cost carbon capture gets X-rayed 2Low-cost carbon capture gets X-rayed 3
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
... N-terminal kinase (JNK) is one of the ... has been used as a sensitive reporter ... provides a 1000-fold increase in sensitivity in ... assay. Firefly luciferase catalyzes the oxidative carboxylation ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: filling ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: cap, ...
Biology Products: